Actively Recruiting
NeoDoppler Ultrasound Technology for Continuous Brain Blood Flow Monitoring in Newborns and Infants up to 1 Year
Led by St. Olavs Hospital · Updated on 2026-04-23
180
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate a new ultrasound technology called NeoDoppler that continuously monitors cerebral blood flow in sick and preterm infants. The technology, CE-certified in 2022, is designed to help understand blood flow variations in neonates with various medical conditions such as patent ductus arteriosus, perinatal asphyxia, stroke, pulmonary hypertension, congenital heart disease, infection, sepsis, and meningitis. The study includes both healthy preterm and term infants as well as those requiring medical procedures. The NeoDoppler device is small and lightweight, designed to be gently fixed over the babys fontanelle. It can measure blood flow at different brain depths simultaneously and is easier to use than standard Doppler devices, as it requires less specialized training. The study will include groups of infants based on gestational age, medical conditions, and those undergoing procedures to map cerebral blood flow variability and responses during interventions. Participants will undergo continuous cerebral Doppler velocity measurements from 2 hours up to 7 days. Researchers will assess measurement quality and track cerebral blood flow changes during various conditions and procedures. The study involves monitoring neonates in a clinical setting with the device compatible alongside other intensive care equipment and caregiving from parents, aiming to gather detailed information on brain blood flow in this vulnerable population.
CONDITIONS
Brief Title
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
Research Team
S
Siri Ann Nyrnes, MD, PhD
S
Siv Steinsmo Ødegård, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here